CANTAB Connect Research™
CANTAB Connect Research™
Find out more about our technologies and statistical consultancy to maximise your cognitive research goals.
Save me for later
Lastest news, publications & insights
First new CANTAB® product features developed & launched from the landmark INTUITION project
First new CANTAB® product features developed & launched from the landmark INTUITION project Cambridge Cognition (AIM: COG), the neuroscience technology company, announces two new product...
C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer’s Trust to Improve Alzheimer’s Disease Diagnosis
Collaboration integrates cognitive assessment, proprietary blood test, national phlebotomy and MRI infrastructure to accelerate patient diagnosis and care pathways throughout the UK.
Integrating Blood-Based Biomarkers & Digital Cognitive Assessments to Accelerate Brain Health Research
The Convergence: Integrating Blood Biomarker Tests and Digital Cognition to Accelerate Alzheimer’s Research The paradigm for diagnosing and monitoring Alzheimer’s disease (AD) is shifting from...
Bringing Trial Activities to the Participant – Lessons from the RADIAL Proof-of-Concept Trial
Bringing Trial Activities to the Participant Lessons from the RADIAL Proof-of-Concept Trial The move toward more participant-centric clinical research has taken an important step forward....
Talk to us about your study
If you would like to find out more about how CANTAB Connect Research can help you achieve your study objectives, complete the form below and one of our experts will be in touch.
